Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,344 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy.
Reis H, Metzenmacher M, Goetz M, Savvidou N, Darwiche K, Aigner C, Herold T, Eberhardt WE, Skiba C, Hense J, Virchow I, Westerwick D, Bogner S, Ting S, Kasper S, Stuschke M, Nensa F, Herrmann K, Hager T, Schmid KW, Schuler M, Wiesweg M. Reis H, et al. Among authors: herrmann k. Clin Lung Cancer. 2018 Jul;19(4):e441-e463. doi: 10.1016/j.cllc.2018.03.010. Epub 2018 Mar 17. Clin Lung Cancer. 2018. PMID: 29631966
11C-MET PET/MRI for detection of recurrent glioma.
Deuschl C, Kirchner J, Poeppel TD, Schaarschmidt B, Kebir S, El Hindy N, Hense J, Quick HH, Glas M, Herrmann K, Umutlu L, Moenninghoff C, Radbruch A, Forsting M, Schlamann M. Deuschl C, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):593-601. doi: 10.1007/s00259-017-3916-9. Epub 2017 Dec 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 29282517
Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients: Preliminary results.
Sarabhai T, Tschischka A, Stebner V, Nensa F, Wetter A, Kimmig R, Forsting M, Herrmann K, Umutlu L, Grueneisen J. Sarabhai T, et al. Among authors: herrmann k. Clin Imaging. 2018 May-Jun;49:163-168. doi: 10.1016/j.clinimag.2018.03.009. Epub 2018 Mar 13. Clin Imaging. 2018. PMID: 29554613
CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor.
Zaun G, Schuler M, Herrmann K, Tannapfel A. Zaun G, et al. Among authors: herrmann k. Dtsch Arztebl Int. 2018 Mar 9;115(10):157-162. doi: 10.3238/arztebl.2018.0157. Dtsch Arztebl Int. 2018. PMID: 29587959 Free PMC article. Review.
Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer.
Kirchner J, Sawicki LM, Nensa F, Schaarschmidt BM, Reis H, Ingenwerth M, Bogner S, Aigner C, Buchbender C, Umutlu L, Antoch G, Herrmann K, Heusch P. Kirchner J, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):437-445. doi: 10.1007/s00259-018-4109-x. Epub 2018 Aug 3. Eur J Nucl Med Mol Imaging. 2019. PMID: 30074073 Clinical Trial.
Assessment of Ileocolonic Inflammation in Crohn's Disease: Which Surrogate Marker Is Better-MaRIA, Clermont, or PET/MR Index? Initial Results of a Feasibility Trial.
Li Y, Langhorst J, Koch AK, Demircioglu A, Nensa F, Kirchner J, Beiderwellen K, Catalano O, Forsting M, Herrmann K, Umutlu L. Li Y, et al. Among authors: herrmann k. J Nucl Med. 2019 Jun;60(6):851-857. doi: 10.2967/jnumed.118.216937. Epub 2018 Nov 2. J Nucl Med. 2019. PMID: 30389814 Free PMC article.
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial.
Guberina M, Eberhardt W, Stuschke M, Gauler T, Aigner C, Schuler M, Stamatis G, Theegarten D, Jentzen W, Herrmann K, Pöttgen C. Guberina M, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1439-1447. doi: 10.1007/s00259-019-4270-x. Epub 2019 Feb 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 30710323 Clinical Trial.
1,344 results